U.S. Software Stock News

NYSE:RSG
NYSE:RSGCommercial Services

Assessing Republic Services (RSG) Valuation As Recent Returns Contrast With Long Term Gains

What recent returns say about Republic Services Republic Services (RSG) traded around $209.22 at the last close, with the stock showing a 0.4% gain over the past day but a 2.3% decline over the past week. Over the past month, Republic Services has recorded a 4.5% decline. The past three months show a 2.7% decline, set against a roughly flat year-to-date performance and a 15.2% negative total return over one year. See our latest analysis for Republic Services. Recent trading points to fading...
NYSE:KKR
NYSE:KKRCapital Markets

Is It Too Late To Consider KKR (KKR) After Its Recent Share Price Recovery?

Wondering if KKR at around US$104 per share offers good value or just headline noise? This article breaks down what that price could mean for you as an investor. The stock has returned 2.7% over the past week and 12.8% over the last 30 days, while year to date it is down 19.1% and the 1 year return sits at an 8.3% decline, against a 3 year return of 115.1% and a 5 year return of 88.8%. Recent coverage has focused on KKR's position as a major alternative asset manager and its role in large...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Is It Too Late To Consider Apple (AAPL) After Its Strong Five Year Run?

Wondering if Apple is still fairly priced after its long run, or if the current share price is starting to stretch what you are getting for your money. Apple shares last closed at US$271.35, with returns of 6.9% over 30 days, 27.8% over 1 year and 114.7% over 5 years, which can shift how the market thinks about both upside and risk. Recent headlines have continued to focus on Apple's product ecosystem and its role within the broader tech sector. This often shapes sentiment around long term...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

How Investors Are Reacting To MarketAxess (MKTX) Special-Meeting Showdown And Board Committee Shake-Up

In April 2026, MarketAxess Holdings filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to allow investors holding 10% of outstanding stock to call special shareholder meetings, while also reshuffling board committee assignments effective May 1, 2026. This governance clash over special meeting rights highlights tensions between management control and shareholder influence at a time when analysts are increasingly optimistic about MarketAxess’s...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Is It Time To Reassess JetBlue Airways (JBLU) After Recent Share Price Swings?

If you are wondering whether JetBlue Airways at around US$4.66 offers value or just more volatility, the key is to understand what the current price actually reflects about the business. The stock has had a mixed run, with an 11.3% decline over the last 7 days, a 5.3% gain over 30 days, year to date returns of 1.4%, and a 6.3% return over the past year, sitting against much weaker 3 and 5 year results of 31.5% and 75.9% declines. These swings have come alongside ongoing headlines about the...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Assessing Zoetis (ZTS) Valuation After A Year Of Weak Shareholder Returns

Recent share performance and what it means for Zoetis investors Zoetis (ZTS) has drawn fresh attention after a challenging run for the stock, with the share price showing negative returns over the past month, past 3 months, year to date, and over the past year. For investors following the animal health group, this weak price performance contrasts with a business that reported US$9.47b in revenue and US$2.67b in net income, supported by mid single digit annual growth in both measures. See our...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP Results, Dividend And Buyback Highlight Capital Allocation And Ownership

XP Inc. (NasdaqGS:XP) released its audited 2025 annual results, giving investors a detailed view of the company’s most recent financial year. The company announced a new cash dividend, signaling a direct return of capital to shareholders. XP also launched a fresh share repurchase program and reported significant ownership positions held by institutional investors. XP operates as a financial services platform, connecting retail and institutional clients to investment products and advisory...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GFS’s Silicon Photonics Focus at Microelectronics US 2026 Reframing Its Specialty-Tech Narrative?

GLOBALFOUNDRIES Inc. recently participated in Microelectronics US 2026, where Director of Product Management Itisha Tyagi and Sr Engineer Manimozhi Sekar delivered presentations on April 22–23 focused on test engineering and silicon photonics. The company’s emphasis on silicon photonics at this conference highlights its push into advanced photonic solutions that could influence how customers view its specialty technology roadmap. We’ll now examine how GLOBALFOUNDRIES’ focus on silicon...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

A Look At AppFolio (APPF) Valuation After Strong Q1 Earnings And Higher 2026 Revenue Guidance

Why AppFolio (APPF) Is Back on Investors' Radar AppFolio (APPF) has drawn fresh attention after its first quarter update, which paired new earnings figures with higher full year revenue guidance and a leadership move in product management. For the quarter ended March 31, 2026, AppFolio reported sales of US$262.21 million compared with US$217.7 million a year earlier. Net income was US$42.42 million compared with US$31.38 million, with basic earnings per share from continuing operations at...
NYSE:GBCI
NYSE:GBCIBanks

Glacier Bancorp (GBCI) Valuation Check After Strong First Quarter Earnings Attract Fresh Market Attention

Glacier Bancorp (GBCI) drew fresh attention after reporting first quarter 2026 results, with net interest income of US$268.68 million and net income of US$82.14 million, alongside higher net charge-offs of US$3.06 million. See our latest analysis for Glacier Bancorp. The first quarter update landed against a backdrop of solid recent momentum, with an estimated 9.8% 1 month share price return and 9.9% year to date share price return. The 1 year total shareholder return of about 23% sits...
NYSE:OLN
NYSE:OLNChemicals

Olin ESOP Shelf Raises Dilution Questions Against Valuation Upside Signals

Olin (NYSE:OLN) has filed a US$123 million shelf registration for an ESOP related offering. The filing covers up to 4.5 million shares of common stock for an employee stock ownership plan. The move introduces a potential source of new shares that could affect capital structure and employee incentives. Olin, a chemicals and ammunition producer, operates across industrial demand, construction activity, and defense related spending. ESOP structures are one way companies tie employee interests...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

ARK Invest Backs Robinhood As Singapore Approval Shifts Growth Focus

ARK Invest purchased over US$39 million of Robinhood Markets (NasdaqGS:HOOD) shares shortly after the company reported a Q1 earnings miss and a substantial decline in crypto revenue. Robinhood received in principle regulatory approval to launch securities brokerage services in Singapore, advancing its international expansion plans. These developments arrive as investor attention is focused on Robinhood's business mix and long term direction beyond near term trading and crypto...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

A Look At Fluence Energy (FLNC) Valuation After Analyst Downgrades And Battery Oversupply Concerns

Fluence Energy (FLNC) is back in focus after UBS downgraded the stock to Sell, citing rising competition and potential battery oversupply. Citi also flagged a more cautious near term outlook for alternative energy equipment. See our latest analysis for Fluence Energy. The recent analyst downgrades and concerns about battery oversupply have come after a sharp reset in sentiment, with a 90 day share price return of 60.42% decline and a year to date share price return of 47.07% decline, even...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

How Moderna (MRNA) Is Recasting Its Vaccine Platform After EU Approval of Its First Combo Shot

In April 2026, the European Commission granted marketing authorization for Moderna’s mCOMBRIAX (mRNA-1083), the first approved mRNA combination influenza and COVID-19 vaccine for adults aged 50 and over across the EU, Iceland, Liechtenstein, and Norway. Around the same time, the Global Virus Network publicly backed Moderna’s progress on its mRNA H5N1 avian influenza vaccine, underscoring how the company’s mRNA platform is being applied to multiple high-impact respiratory threats beyond...
NYSE:NIQ
NYSE:NIQMedia

Is NIQ Global Intelligence (NIQ) Offering An Opportunity After This Year’s 30% Share Price Slide

This article considers whether NIQ Global Intelligence, at around US$10.93, offers value or simply appears cheap on the surface by examining what the current price might really imply. The share price has eased back recently, with a 7‑day return of a 2.6% decline, a 30‑day return of a 3.9% decline, and a year‑to‑date return of a 30.7% decline. Recent coverage has focused on the stock's weaker near‑term returns and what they might signal about investor expectations, which helps explain why...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Q3 Profit Challenges Bearish Narratives On Persistent Losses

Viavi Solutions (VIAV) just posted Q3 2026 results with revenue of US$406.8 million and basic EPS of US$0.03, while on a trailing twelve month basis revenue stands at US$1.4 billion with a basic EPS loss of US$0.24. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$406.8 million in Q3 2026, alongside basic EPS shifting from US$0.04 in Q2 2025 to US$0.03 in the latest quarter and swinging between profits and losses in the periods in between. This...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Arch Capital Group (ACGL) Valuation Check After Recent Short Term Share Price Swings

Short term swings and longer term returns Arch Capital Group (ACGL) has seen mixed recent share price moves, with a 1 day return of 1.9%, a 7 day decline of 3.7%, and modestly negative performance over the month and past 3 months. Even with this recent softness, the stock shows a 1 year total return of 5.3% and stronger cumulative gains over 3 and 5 years, which can help you compare recent volatility with longer holding periods. See our latest analysis for Arch Capital Group. Recent trading...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Net Margin Of 8.8% Tests Bullish Profit Expansion Narrative

ATI (ATI) has opened Q1 2026 earnings season with Q4 2025 revenue of US$1.2 billion and basic EPS of US$0.71, setting the stage against a current share price of US$155.46 as investors focus on how these results fit into the company’s recent earnings trajectory. Over the past year, quarterly revenue has ranged from US$1.1 billion to US$1.2 billion, while basic EPS has moved between US$0.64 and US$0.80. This provides a clear view of how the top and bottom line have tracked together across...
NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle Mines (AEM) Is Down 5.4% After Earnings Beat, Dividend Hike, and Finland Acquisitions

Agnico Eagle Mines Limited recently reported first-quarter 2026 results, with net income rising to US$1.70 billion from US$814.73 million a year earlier and basic earnings per share from continuing operations increasing to US$3.39 from US$1.62. The company paired these stronger margins and earnings with a US$0.45 per-share dividend, share repurchases, and new acquisitions in Finland that consolidate control over the Central Lapland Greenstone Belt and the Ikkari gold project. We’ll now...
NasdaqGS:INBX
NasdaqGS:INBXBiotechs

A Look At Inhibrx Biosciences (INBX) Valuation After New Ozekibart Data And BLA Submission

Why the latest ozekibart update matters for Inhibrx Biosciences investors Inhibrx Biosciences (INBX) has drawn fresh attention after releasing updated interim data for ozekibart in colorectal cancer and submitting a Biologics License Application for the drug in conventional chondrosarcoma. See our latest analysis for Inhibrx Biosciences. The latest ozekibart updates arrive against a backdrop of intense trading interest, with the share price at US$129.21 and a 30 day share price return of...
NYSE:AWR
NYSE:AWRWater Utilities

A Look At American States Water (AWR) Valuation After Recent Share Price Pullback

Key recent performance for American States Water American States Water (AWR) has been relatively steady recently, with the stock showing a small move over the past month and a modest positive return in the past 3 months, despite a negative 1 year total return. See our latest analysis for American States Water. The recent pullback, with a 1 day share price return of a 3.31% decline and a 7 day share price return of a 6.82% decline from US$75.29, contrasts with a year to date share price gain...
NYSE:RPM
NYSE:RPMChemicals

A Look At RPM International (RPM) Valuation As Mixed Returns Contrast With Undervalued Narrative

RPM International: recent performance snapshot RPM International (RPM) shares recently closed at US$101.89, with mixed return patterns across different holding periods that may catch your eye if you track both shorter swings and multi year performance. See our latest analysis for RPM International. Recent price action has been choppy, with a 1 day share price return of 1.19% and a 30 day share price return of 2.50% set against a 1 year total shareholder return of a 3.40% decline. This points...
NYSE:FCN
NYSE:FCNProfessional Services

FTI Consulting (FCN) Margin Slippage Revives Bearish Narrative Ahead Of Q1 2026 Earnings

FTI Consulting (FCN) has opened 2026 with investors focused on how its latest quarter measures up to a steady run of results that most recently saw Q4 2025 revenue of US$990.7 million and basic EPS of US$1.80, supported by trailing 12 month basic EPS of US$8.33 on revenue of about US$3.8 billion. Over the past few quarters the company has seen revenue move from US$894.9 million in Q4 2024 to US$898.3 million in Q1 2025 and then to US$990.7 million in Q4 2025, while basic EPS has ranged from...